Corbus Pharmaceuticals Holdings (CRBP) Invested Capital (2021 - 2024)

Corbus Pharmaceuticals Holdings' Invested Capital history runs 4 years deep, the most recent figure standing at $10.7 million for Q2 2024.

• In Q2 2024, Invested Capital fell 41.4% year-over-year to $10.7 million; the TTM figure through Mar 2025 stood at $10.7 million (down 83.43% YoY), while the FY2023 annual figure was $15.9 million, down 15.29% from the prior year.
• Invested Capital for Q2 2024 stood at $10.7 million, down from $12.8 million in the prior quarter.
• The five-year high for Invested Capital was $19.3 million in Q3 2022, with the low at $10.7 million in Q2 2024.
• The 4-year median for Invested Capital is $18.7 million (2021), against an average of $17.2 million.
• The sharpest annual moves came in 2023 and 2024: Invested Capital advanced 0.4% in 2023, then sank 41.4% in 2024.
• Corbus Pharmaceuticals Holdings' Invested Capital stood at $18.7 million in 2021, then rose by 0.27% to $18.8 million in 2022, then dropped by 15.29% to $15.9 million in 2023, then plunged by 32.46% to $10.7 million in 2024.
• Business Quant data shows CRBP's Invested Capital at $10.7 million in Q2 2024, $12.8 million in Q1 2024, and $15.9 million in Q4 2023.